[ALA] QoQ Quarter Result on 30-Sep-2019 [#Q1]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
29-Sep-2019
Financial Year
2020
Quarter
30-Sep-2019 [#Q1]
Profit Trend
QoQ- 44.40%
YoY- -785.06%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 163 106 370 192 396 198 427 -47.40%
PBT -2,892 -1,446 -7,699 -3,850 -7,850 -3,925 -435 253.97%
Tax -656 -328 0 0 -925 463 0 -
NP -2,236 -1,118 -7,699 -3,850 -6,925 -3,462 -435 198.14%
Tax Rate - - - - - - - -
Total Cost 2,399 1,224 8,069 4,041 7,321 3,660 862 97.97%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -1,372.98 -1,053.37 -2,081.94 -2,008.97 -1,748.22 -1,748.22 -101.83 467.38%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.01 -0.01 -0.05 -0.03 -0.04 -0.03 -0.00 -
EPS Diluted -0.01 -0.01 -0.05 -0.03 -0.04 -0.03 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.